Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.73 USD | +2.69% | +8.79% | -11.16% |
03-18 | Forte Biosciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
01-05 | Camac Partners Provides Information to Shareholders | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationQuarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-11.16% | 25.87M | |
+3.26% | 106B | |
+7.02% | 23.47B | |
-14.75% | 21.9B | |
-7.05% | 18.77B | |
-38.55% | 17.85B | |
-9.38% | 16.78B | |
+6.40% | 14.41B | |
+34.71% | 12.86B | |
+315.96% | 8.78B |
- Stock Market
- Equities
- FBRX Stock
- News Forte Biosciences, Inc.
- Forte Biosciences : Brookline Capital Downgrades Forte Biosciences to Hold from Buy